Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$79.94

-1.29 (-1.59%)

09:15
03/25/19
03/25
09:15
03/25/19
09:15

AbbVie downgraded to Hold from Buy at Argus

As previously reported, Argus analyst David Toung downgraded AbbVie to Hold, saying its flagship program Humira "no longer looks invulnerable to competition from biosimilars in Europe and other overseas markets." The analyst notes that Humira is also faced with "indirect competition from newer drugs that have an alternative mechanism of action" compared to Humira's anti-TNF class. Toung further cites AbbVie's clinical setback with Venclexta, which highlights the risks for the company as it develops a pipeline aimed to offset the expected decline in Humira sales.

  • 25

    Mar

  • 18

    May

ABBV AbbVie
$79.94

-1.29 (-1.59%)

02/21/19
PIPR
02/21/19
NO CHANGE
Target $90
PIPR
Neutral
Piper doctor surveys show further Humira erosion outside the U.S.
Piper Jaffray analyst Christopher Raymond says new European rheumatologist and dermatologist surveys suggest further downside potential for branded Humira erosion at the hands of biosimilar competition. While AbbVie management has downwardly revised Humira outside the U.S. erosion estimates twice in recent months, we likely haven't seen the last such revision, Raymond tells investors in a research note. European doctors project that biosimilars will capture 30%-40% of adalimumab use by mid-2019, which contrasts with management's 30% fiscal 2019 erosion commentary, adds the analyst. He now models a 35% ex-U.S. fiscal 2019 Humira erosion, but fears it could be worse. Raymond continues to urge caution on shares of AbbVie, "despite a healthy 5.4% dividend yield." He keeps a Neutral rating on the stock with a $90 price target.
02/25/19
ADAM
02/25/19
NO CHANGE
Target $26
ADAM
Buy
Voyager Therapeutics deal validates CNS gene therapy platform, says Canaccord
Canaccord analyst Sumant Kulkarni noted Abbvie (ABBV) and Voyager Therapeutics (VYGR) expanded their collaboration agreement to work on Parkinson's in addition to their previous collaboration on Alzheimer's. The analyst believes the deal further validates Voyager's central nervous system gene therapy platform. Kulkarni believes Voyager shares are undervalued and he reiterated his Buy rating and $26 price target on the stock.
03/13/19
PIPR
03/13/19
NO CHANGE
Target $90
PIPR
Neutral
Piper dermatologist survey offers 'good news/bad news' for AbbVie
Piper Jaffray analyst Christopher Raymond views his firm's survey of 101 U.S. dermatologists as "good news/bad news" for AbbVie's dermatology franchise. On the positive side, due to both AbbVie's "significant goodwill" as well as risankizumab's superior clinical profile, dermatologists indicate "significant uptake" of the drug once approved, Raymond tells investors in a research note. On the negative side, Humira continues to lose market share to newer biologics like anti-IL-17s and approved anti-IL-23s at a "rapid pace" that may be accelerated by cannibalization at the hands of risankizumab, adds the analyst. Following the surgery, Raymond remains comfortable with his below-consensus AbbVie revenue estimates this year and next. He keeps a Neutral rating on the shares with a $90 price target.
03/25/19
ARGS
03/25/19
DOWNGRADE
ARGS
Hold
AbbVie downgraded to Hold from Buy at Argus

TODAY'S FREE FLY STORIES

CL

Colgate-Palmolive

$67.65

0.43 (0.64%)

11:45
12/13/19
12/13
11:45
12/13/19
11:45
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
12/13/19
12/13
11:45
12/13/19
11:45
General news
NY Fed's Williams said the economy is in a very good place »

NY Fed's Williams…

AMN

AMN Healthcare

$59.29

-0.77 (-1.28%)

11:43
12/13/19
12/13
11:43
12/13/19
11:43
Conference/Events
AMN Healthcare participates in a conference call with Benchmark »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

BBBY

Bed Bath & Beyond

$15.19

-0.64 (-4.04%)

11:35
12/13/19
12/13
11:35
12/13/19
11:35
Options
Bed Bath & Beyond put volume heavy and directionally bearish »

Bearish flow noted in Bed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

TNDM

TNDM

11:34
12/13/19
12/13
11:34
12/13/19
11:34
Hot Stocks
Breaking Hot Stocks news story on TNDM »

Tandem Diabetes trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$18.70

-0.17 (-0.90%)

11:31
12/13/19
12/13
11:31
12/13/19
11:31
Conference/Events
Tilray conference call will now be held on December 18 hosted by Benchmark »

Cannabis Analyst Hickey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

ET

Energy Transfer LP

$12.51

-0.15 (-1.19%)

11:25
12/13/19
12/13
11:25
12/13/19
11:25
Options
Energy Transfer call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

OGI

Organigram

$2.60

0.035 (1.36%)

11:25
12/13/19
12/13
11:25
12/13/19
11:25
Conference/Events
Organigram management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNP

CenterPoint Energy

$25.47

0.64 (2.58%)

11:19
12/13/19
12/13
11:19
12/13/19
11:19
Periodicals
CenterPoint Energy in talks to settle on Texas rates, Bloomberg says »

Bloomberg cites a filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPT

Sprout Social

$0.00

(0.00%)

11:18
12/13/19
12/13
11:18
12/13/19
11:18
Syndicate
Breaking Syndicate news story on Sprout Social »

Sprout Social indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/13/19
12/13
11:17
12/13/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/13/19
12/13
11:16
12/13/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$5.37

-0.26 (-4.62%)

11:15
12/13/19
12/13
11:15
12/13/19
11:15
Options
Express put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSVI

Computer Services

$0.00

(0.00%)

11:13
12/13/19
12/13
11:13
12/13/19
11:13
Hot Stocks
Computer Services names Brian K. Brown as permament CFO »

Computer Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.60

-0.08 (-0.28%)

11:10
12/13/19
12/13
11:10
12/13/19
11:10
Periodicals
Uber submits appeal to restore taxi license in London, Reuters reports »

Uber has submitted an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

SNAP

Snap

$14.78

0.33 (2.28%)

, REGN

Regeneron

$376.32

4.22 (1.13%)

11:08
12/13/19
12/13
11:08
12/13/19
11:08
On The Fly
Snap upgrade, Sarepta target raises among today's top analyst actions »

Check out today's top…

SNAP

Snap

$14.78

0.33 (2.28%)

REGN

Regeneron

$376.32

4.22 (1.13%)

OIS

Oil States

$16.67

-0.965 (-5.47%)

PTEN

Patterson-UTI

$10.05

-0.33 (-3.18%)

SRPT

Sarepta

$133.84

33.45 (33.32%)

GILD

Gilead

$66.05

-1.59 (-2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 23

    Mar

NUE

Nucor

$57.08

-1.03 (-1.77%)

11:05
12/13/19
12/13
11:05
12/13/19
11:05
Hot Stocks
Nucor raises quarterly cash dividend to 40.25c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.40

0.13 (2.47%)

11:05
12/13/19
12/13
11:05
12/13/19
11:05
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
12/13/19
12/13
11:00
12/13/19
11:00
General news
Today's U.S. reports »

Today's U.S. reports…

GPS

Gap

$16.66

-0.36 (-2.12%)

10:55
12/13/19
12/13
10:55
12/13/19
10:55
Options
Gap put volume heavy and directionally bearish »

Bearish flow noted in Gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
12/13/19
12/13
10:55
12/13/19
10:55
Conference/Events
Federal Reserve Bank of New York president participates in a discussion »

New York Federal Reserve…

SPT

Sprout Social

$0.00

(0.00%)

10:52
12/13/19
12/13
10:52
12/13/19
10:52
Syndicate
Sprout Social indicated to open at $19.25, IPO priced at $17.00 »

Sprout Social (SPT)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.49

0.35 (0.11%)

10:47
12/13/19
12/13
10:47
12/13/19
10:47
General news
U.S. Trade Representative says Phase One trade deal with China 'enforceable' »

United States Trade…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$317.49

0.35 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$286.83

3.03 (1.07%)

10:45
12/13/19
12/13
10:45
12/13/19
10:45
Options
UnitedHealth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/13/19
12/13
10:45
12/13/19
10:45
General news
Breaking General news story  »

New York Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.